Gut health

At Genetic Analysis we are improving gut health every day!

Sign up for our gut microbiota newsletter

Ronny i labben avtrekk
  • 7
    Dec
  • Image

BIOASTER collaborates with Bio-Rad and Genetic Analysis to develop novel microbiome-based diagnostics within the field of metabolic disorders

Lyon, December 6th, 2018 BIOASTER, the French Technology Research Institute for Microbiology and Infectious Diseases, today announced the initiation of a collaborative program with BIOASTER, BioRad Laboratories, Inc. and Genetic Analysis aimed at evaluating microbial dysbiosis signatures in the field...

Read More
Slide-1
  • 12
    Jan
  • Image

Gut microbial composition identifies patients that respond to dietary FODMAP restriction

(Oslo, Norway) In a new study, scientists have developed a response index (RI) to identify which patients with irritable bowel syndrome (IBS) would benefit from a low FODMAP diet. The RI is based on 10 fecal bacterial markers included in...

Read More
Microbiome MDx specialist Genetic Analysis signs supply & distribution agreement with Bio-Rad for GA-map™
  • 13
    Dec
  • Image

Microbiome MDx specialist Genetic Analysis signs supply & distribution agreement with Bio-Rad for GA-map™

Press Release:  Dysbiosis success triggers further investment and development agreement for additional microbiome tests beyond GA-map™ Dysbiosis Test (Oslo and Hercules, Calif., 12 December 2017) Genetic Analysis (GA) and Bio-Rad Laboratories, Inc., a global provider of life science research and...

Read More
IBD children infographics
  • 30
    May
  • Image

Severity prediction of inflammatory bowel disease in children

(Prague, May 13, 2017) The results from a Norwegian study show that a new genetic test for characterizing intestinal microbiota may help to diagnose inflammatory bowel disease in children and predict which children will develop the most extensive disease and...

Read More
GA-map™ Dysbiosis Test on the Luminex instrument platform.
  • 9
    May
  • Image

Luminex and GA enter into an agreement

Genetic Analysis (GA) and Luminex Corp. Inc (Luminex) has entered into an agreement whereby GA will have the right to develop, market and sell the GA-map™ Dysbiosis Test on the Luminex instrument platform. Luminex is known for its "state of...

Read More
Bio-rad and Genetic Analysis
  • 29
    Nov
  • Image

Bio-Rad and Genetic Analysis Sign Agreement

Press Release: Bio-Rad to Commercialize Genetic Analysis’s GA-map Technology for the Detection of Gut Dysbiosis (Oslo and Hercules, Calif., 28 November 2016) Genetic Analysis (GA) and Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic  products, today...

Read More
low-fodmap-word-cloud
  • 18
    Oct
  • Image

GA-map™ Dysbiosis Test in new breakthrough for IBS patients

(Vienna, October 18, 2016) A low-FODMAP diet is now an established treatment for people with irritable bowel syndrome (IBS), but the diet is controversial and challenging to follow, and not all IBS sufferers have a positive response to the intervention....

Read More
NEC
  • 27
    Jul
  • Image

US Patent for Necrotizing Enterocolitis (NEC) Granted

  Press Release (Oslo, 27. July 2016) Genetic Analysis AS today announces that it has been granted a US patent (Patent No. 9376724) for a method for identifying neonates at risk for necrotizing enterocolitis. NEC is a gastrointestinal (GI) tract...

Read More
Bacteria IBD
  • 13
    Apr
  • Image

Microbiota in IBD  – ECCO 2016

(Amsterdam, March 16th 2016) Genetic Analysis AS has reported preliminary results in the pan European study “IBD Character” at the European Crohn’s and Colitis Organization’s (ECCO) Annual congress. Using the proprietary GA-map™ Dysbiosis Test, fecal microbiota dysbiosis patterns revealed that IBD...

Read More
Patent
  • 12
    Apr
  • Image

Genetic Analysis granted US and European patent for oligonucleotide probe set and methods of microbiota profiling

(Oslo, April 12th 2016) Genetic Analysis AS today announces that it has been granted a US patent (Patent No. 9243297) and a European patent (Patent No. 2652145) for its technology governing the oligonucleotide probe set and methods of microbiota profiling....

Read More